re: Ann: Appendix 4D and Interim Financial Re...
ISN report was pathetic. The only fortunate thing about Thomas taking over was some of us stale holders were given a life line. $11K in operating revenues?
Here's a summary of their report this time last year:
Just one year ago, a new management team defined a fresh direction and strategic path for the Company, recognising that its novel ARM technology could realise more benefit for asthma patients and families through mHealth platforms and direct-to-consumer demand creation than being dependent upon the existing technological platforms and a traditional medical sales force. The first AsthmaSense app was launched to consumers in Q1 FY2013 and, with the installed base now approaching 10,000, the word of mouth has been posi tive, underscoring a widely felt need for better as thma management tools. With the launch of the AsthmaSen se Cloud and the increased risk prediction capabili ties of AsthmaSense Prime, the neural network asthma data service, our advertising and promotion will ramp up to generate more robust adoption. Also in Q2 calendar 2013, we will begin to aggressively promote the need for better monitoring to achieve better asthma management. The market shaping initiatives will involve educational and social media to create early awareness and anticipation for AirSonea among asthmatic adults and parents of children with asthma. We are committed to bringing innovative, class-leading products to market that will set a new standard for asthma monitoring and management. We thank our shareholders for providing the support and resources to enable us to fulfil this promise in 2013.
Apparently this was the NEW management team with new ideas. Well luckily we now in 2014 have a NEW NEW management team with new ideas. Until next year....
ISN Price at posting:
23.0¢ Sentiment: None Disclosure: Held